The order for China Biologic’s Human Immunoglobulin for IV Injection 5g/100ml product will be delivered to the distributor over a nine-month period, commencing June 2009.
The company believes that this sales order, the second one to India, represents the growing international recognition of the company’s brand and of its reputation for producing high quality biopharmaceutical products.
Chao Zhao, CEO of China Biologic Products, said: “We are pleased to announce another order for the international market, especially one significantly larger than our first. We view this order as a validation of the high quality of our products, and as a sign of increasing recognition by the global marketplace.”